Alontrus Group Sponsors the NJ Hyperledger Meetup to Introduce Alibaba Cloud, Blockchain and Cloud Computing Solutions

An Educational and Networking Event to Discuss Hyperledger 2.0, Enterprise Ethereum Platform, Alibaba Cloud and DataKNOX™- A Distributed Ledger Technology.

MORRISTOWN, NEW JERSEY, USA, February 24, 2020 /EINPresswire.com/ — Alontrus Group, headquartered in New York, New York, joins Chainbelow, a not for profit education firm based in northern New Jersey, to present an educational and networking event to discuss the recent release of Hyperledger 2.0, the Enterprise Ethereum Platform, Alibaba Cloud and DataKNOX™- A Distributed Ledger Technology (DLT).

Alontrus Group will unveil DataKNOX™, the next generation of DLT. DataKNOX™ is a high-speed centralized authority that eliminates the overhead of consensus algorithms. Hashing files ensures data integrity and SHA-512 encryption ensures data security. DataKNOX™ is an immutable, append only database that provides provenance for sensitive data. For reliability, DataKNOX™ is self-replicating across hundreds of cloud instances. DataKNOX™ also provides secure high-speed data transport to enhance cloud migration. All the features of Blockchain in a light weight distributed ledger.

Alontrus Group, LLC has launched with a team of seasoned Blockchain and DLT veterans to address reconciliation challenges in the Healthcare, Banking, Financial Services and Insurance sectors. The group has an extensive partner network and a portfolio of use cases across Oracle, AWS, Alibaba Cloud, Google Cloud, and Microsoft Azure, based on Hyperledger Fabric and DLT.

The Hyperledger networking and educational event will be held at the Morris County Library in Whippany, NJ on February 26, from 4:30 to 8:30 pm. The Hyperledger and Enterprise Blockchain communities are invited to attend. Food and refreshments will be provided and an opportunity to win a $100 Ruth Chris gift card.

Space is limited so please register at Hyperledger MeetUp NJ. A $5 donation is suggested.

About Alontrus Group:
Alontrus Group automates reconciliation and settlement processes using Blockchain and Next Gen technologies for Healthcare and Corporate Finance. They are Protocol, Cloud and Platform agnostic, based in the U.S.A. with global resources. Their in-depth knowledge of various enterprise blockchains and cloud platforms allows them to offer a unique perspective to their customers.

For more information, contact Richard Brownstein: info@alontrus.com or 917.830.6641

About Chainbelow:
Chainbelow Inc, is a not-for-profit education corporation and an authorized training partner for the Linux Foundation. Members of Chainbelow ensure that the majority of training materials they produce are high performance and open sourced. They provide small and medium-sized organizations with the adequate training to run a software-driven business.

For more information: info@chainbelow.org

Richard Brownstein
Alontrus Group
+1 917-830-6641
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Southeastern Medical Device Association and Southeast BIO Merge to form Southeast Life Sciences

SE Life Science

Southeast Life Science created by merger

Merger of SEMDA and SEBIO results in single Southeastern platform for medtech, bioscience innovation, partnering and investor relations in region

The convergence of medical technologies, including devices, with bioscience technologies including drugs, data, digital and combination products necessitates the convergence of these entities.”

— Jason Rupp, Southeast Life Science Executive Director

ATLANTA, GEORGIA, USA, February 24, 2020 /EINPresswire.com/ — Representatives from the Southeastern Medical Device Association (SEMDA) and Southeast BIO (SEBIO) have announced that the two organizations have officially merged to form Southeast Life Sciences. The merger provides a single platform for medtech and bioscience innovation, partnering and investor relations in the region.

“The convergence of medical technologies, including devices, with bioscience technologies including drugs, data, digital and combination products necessitates the convergence of these entities,” former SEMDA Executive Director and now Southeast Life Science Executive Director Jason Rupp says. “In order to respond to the combined needs of stakeholders in both ecosystems, the time has arrived for SEBIO and SEMDA to come together under one roof.”

Combining individuals, corporations, universities and other entities in one regional industry organization mitigates “death by one thousand conferences,” ensuring more efficient use of time and resources, Rupp says.

New technologies like nanoparticles and microneedles for drug delivery coming out of the Wallace H. Coulter Department of Biomedical Engineering, a joint program of Emory University and Georgia Tech, are tangible examples of the potential for innovation when multiple scientific disciplines connect.

“With the advent of devices like Cardiomems that blend device with data and devices that deliver pharmaceutical therapies, close connectivity between medical device and bioscience innovators is advantageous to regional stakeholders, especially investors,” Rupp says.

“Because clients span the entirety of medtech innovation including devices, pharmaceutical therapies and combination devices, many companies like ours needed to support both organizations,” says former SEMDA Chair Tiffany Wilson, CEO of the Global Center for Medical Innovation (GCMI). “Financially, this meant telling them, ‘We have this amount of funding support for you. You have to figure out how to divvy it up.’ While both SEBIO and SEMDA flagship conferences had value, bringing them under the same roof brings connectivity, educational and financial efficiency gains for all concerned that should lift medtech and life science innovation and investment across the board.”

The inaugural ADVANSE Life Science Conference, Southeast Life Science’s flagship event will be May 28-29, 2020 in Charleston, SC. Organizers expect to convene more than 500 attendees, including a significant number of investors, highlighting innovations from 50 early stage medtech and bioscience companies over the two-day conference.

David Day, Executive Director of Southeast BIO, added, “Southeast BIO and SEMDA have been operating as sister organizations for medtech and life science stakeholders in the southeast. The resulting merger will provide a critical mass of innovation that will be more than the sum of its parts.”

Sam Patrick
Patrick Marketing
+1 864-787-0820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Ethicon Lied to Doctors Regarding the Safety of Their Vaginal Mesh Products

J&J was found by the Court to have used systematic deceptive marketing and is liable under California’s Unfair Competition Law and False Advertising Law.

The door is closing on the mesh manufacturers…as their devices are defectively designed and the risk of severe debilitating pain does not justify their use and the warning is still inadequate.”

— Dr. Greg Vigna

SANTA BARBARA, CALIFORNIA, UNITED STATES, February 24, 2020 /EINPresswire.com/ — As a matter of law, Johnson & Johnson (J&J) lied to consumers regarding the safety and efficacy of their transvaginal mesh product as pronounced in a major ruling by the Honorable Eddie C. Sturgeon in the Superior Court of the State of California in San Diego County, Central Branch, ordering civil penalties in the amount of $343,993,750 to be paid by J&J. Though the company seeks to blame doctors for its misdeeds, it may be more difficult now for J&J to blame them for failing to warn patients of the risks associated with the implantation of their devices via the Learned Intermediary Doctrine. Simply stated, J&J was found by the Court to have used systematic deceptive marketing and is liable under California’s Unfair Competition Law and False Advertising Law.

The California Court found that all of J&J’s “sales training materials and outward-facing marketing materials about J&J’s mesh products-including doctor-directed sales aids, professional education training materials, and patient-directed marketing materials” were approved by the company’s medical, regulatory, and legal management. Unfortunately, for a generation of women, the California Court found that J&J marketing “concealed what they knew about the risks and downplayed FDA warnings."

The California court found that since 2000, a mere two years after the TVT launch, “J&J did not include the risk of or potential need for removal of pelvic mesh in its IFUs until 2015,” and in fact affirmatively acted multiple times to conceal known risks of their transvaginal mesh product lines. An example of this includes in 2005, “Ethicon instructed marketing employee, Kimberly Hunsicker, to remove dyspareunia data from the abstract of a presentation about Prolift because including that information “IS GOING TO KILL US.”

As a Matter of Law, the California Court found that J&J “knew about the risk and dangers of their pelvic mesh devices.” The Court was unconvinced by J&J expert testimony of Dr. Peter Rosenblatt, Dr. Charles Nager, and Dr. Karyn Eilber that “mesh does not cause or pose additional dangers aside from vaginal exposure and erosion.” In fact, the court found that the defense experts’ opinions contradicted the company’s own internal documents “that these mesh properties can lead to multiple serious and long-term complications.”

Not only did the California court find J&J experts’ testimony unconvincing, it found that their testimony was biased, noting that Dr. Rosenblatt has implanted “over 3,000 mesh devices over his career [and] he has also been a paid consultant for almost every U.S. mesh manufacturer for the past 18 years” with compensation “somewhere in the range of $2.2 million to $5.5 million from mesh manufacturers.”

Greg Vigna, MD, JD, practicing physician, national pharmaceutical injury attorney, and Certified Life Care Planner states, “The door is closing on the mesh manufacturers, even with the change in warning, as their devices are defectively designed and the magnitude of the risk of severe debilitating pain does not justify their use and the warning is still inadequate. We are investigating cases involving retropubic slings causing ilioinguinal neuralgia and transobturator slings causing obturator and pudendal neuralgia including those mesh implants inserted by J&J’s unconvincing and biased experts.”

For articles, video resources, and information, visit the Pudendal Neuralgia Educational Portal (https://pudendalportal.lifecare123.com/) or https://tvm.lifecare123.com/. Click here for information regarding sling related complications: https://tvm.lifecare123.com/slingebook.html

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Dr. Bryan White, MD of Hospice Institutes Antidepressant Reduction Protocol for Elderly Patients

DALLAS, TEXAS, USA, February 24, 2020 /EINPresswire.com/ —
Overseeing care at a number of Hospice facilities across Texas, Dr. Bryan White, MD has helped deliver unparalleled care and specialized services to patients and families for decades. In recent years, he’s proposed and instituted a dosage reduction protocol on antidepressant medications for elderly patients at his Hospice and Hospice Plus locations.

Dr. Bryan White, MD of Hospice dedicates his professional time to ensuring patients have a truly individualized approach to care that meets their specific needs. Avoiding the one-size-fits-all approach to care, he instead looks to unique factors in his patients’ health standing to deliver appropriate medication dosages.

In the past few years, Dr. Bryan White, MD of Hospice has looked to open forums to propose potential dosage reduction protocols for his patients. Recognizing that many under his care are at a higher risk of negative side effects of these drugs, he proposed new limits on dosages, which were positively received by his peers during the open forums.

Recently, Dr. White instituted a dosage reduction protocol for antidepressant administration for patients in facilities around Texas. The institution of this protocol means a significant reduction of use of unneeded antidepressant medications, especially in nursing home patients. The protocol has been successful in multiple facilities that provide skilled and long term nursing care.

More careful monitoring and administering of antidepressants for nursing homes patients ultimately cuts down on potential threats that would impede on their good health. Today, Dr. Bryan White, MD of Hospice believes too many medical professionals rely heavily on
antidepressant medications, often using overly broad dosages when prescribing them to patients. He asks his peers to exercise more caution when prescribing them, especially in elderly patients.

“Antidepressants can do a lot of good for people because they balance out chemicals in the
brain called neurotransmitters that determine our mood and how we feel overall,” says Dr. Bryan
White, MD of Hospice. “However, they can be over prescribed and often are never reduced or stopped, especially in elderly patients who may not need these medications indefinitely.”

For decades, the most popular medicine for psychological treatment have been serotonin reuptake inhibitors (SSRIs). These types of medications work by suppressing certain negative feelings or thoughts to help patients overcome symptoms of depression. During regular use, they have proven to help people achieve more peaceful sleep regularly, boost their appetite, and enjoy activities with a more positive overall mood. However, they do have their drawbacks, especially in excessive dosages for elderly patients.

SSRIs are typically viewed as much safer than other forms of antidepressants on the market since they don’t disturb heart rhythms and don’t usually cause harmful side effects like dizziness. However, because liver health is a particular concern of elderly patients, excessive dosages can have a harmful impact.

“By instituting this new protocol, we can reduce the potential harm of antidepressants,” says Dr. Bryan White, MD of Hospice. “Already, it has led to a significant reduction in the use of unneeded antidepressant medications in nursing homes. The protocol has been especially successful in facilities that provide skilled and long term nursing care, helping physicians to prescribe only the safest and most appropriate medications for their elderly patients.”

Caroline Hunter
Web Presence, LLC
+1 7862338220
email us here


Source: EIN Presswire

Foam Swab Manufacturer Super Brush Will Be Exhibiting at Pittcon 2020

Super Brush LLC 800 Worcester St Springfield, MA 01151

Super Brush Foam Swabs

Foam Swab Manufacturer Super Brush Will Be Exhibiting at Pittcon 2020

Foam Swab Manufacturer Super Brush Will Be Exhibiting at Pittcon 2020

Wide-range of foam swabs

Foam swab manufacturer, Super Brush, will be exhibiting their technologically advanced foam swabs at this year’s Pittcon in booth #1646.

Pittcon is a great opportunity for us to engage with many of our customers in the laboratory industries and collaboratively design solutions to meet their challenges”

— Johan Sunryd, Super Brush’s Business Development Manager

SPRINGFIELD, MASSACHUSETTS, US, February 24, 2020 /EINPresswire.com/ — Super Brush LLC will be traveling to Chicago to exhibit at this year’s Pittcon show.

Foam swab manufacturer, Super Brush, will be exhibiting their technologically advanced foam swabs at this year’s Pittcon in booth #1646 at the McCormick Place Conference Center in Chicago, Illinois on March 3-5, 2020.

Pittcon is an annual conference and exposition on laboratory science featuring scientists from all around the world. With more than 2,000 technical sessions and a three-day exhibition, Pittcon makes it easy for visitors to connect to the latest research and developments from leading scientists.
Super Brush will be highlighting their lint-free foam applicators ideal for removing excess residue, powders, liquid, and debris from lab equipment, surfaces and tubing. Swabs are available with handles ranging from 7 cm to as long as 2.5 meters.

“Pittcon is a great opportunity for us to engage with many of our customers in the laboratory industries and collaboratively design solutions to meet their challenges”, explains Johan Sunryd, Super Brush’s Business Development Manager.

“Part of Super Brush’s success over the last six decades has been our ability to engage with nascent technologies and developing custom tools for our customers. This year at Pittcon we are looking forward to seeing our current and prospective customers as well as all the new innovations presented at the show.”

The Super Brush team will be available at booth #1646 to answer any questions about their products. You can also find more information on our complete line of USA-made Super Brush LLC lint-free foam swabs at www.superbrush.com or contact sales@superbrush.com.

For more information about Pittcon 2020 visit https://pittcon.org/pittcon-2020/

About Super Brush

Super Brush LLC specializes in the design, development, and manufacturing of foam swabs and applicators. From applicators to cleanroom compatible swabs, Super Brush provides industries with technically advanced foam swabs for precision cleaning of laboratory equipment and delicate surfaces, collected samples, removing excess materials, applying lubricants, solvents, adhesives, topical antiseptics and a host of other solutions. ISO 13485:2016 certified, FDA registered.

Michael Lecrenski
Super Brush LLC
+ +1 4135431442
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Telemedicine Carts & Systems Market: Size, Share, Outlook, and Global Opportunity Analysis, 2020-2025

Telemedicine Carts & Systems -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, February 24, 2020 /EINPresswire.com/ — Telemedicine Carts & Systems Industry

Description

This report focuses on Telemedicine Carts & Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Telemedicine Carts & Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

The Telemedicine Carts & Systems market is a growing sector with several subsectors such as design, manufacturing, distribution, and after sales services. In the past, the market had seen an increasing curve in the sales chart, but the past few years have been different. The sales of the products from the Telemedicine Carts & Systems market have reduced. The compound annual growth rate which had been increasing steadily from 2020-2025 has remained at x percentage since 2018.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

GlobalMed
Rubbermaid Healthcare
Polycom
Cisco Systems
Ergotron
AVTEQ
AMD
Lifebot
Avizia
ICUcare
METRO
Intouch Health
Afc Industries
AFHCAN

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4942739-global-telemedicine-carts-systems-market-research-report-2020

Segment by Type
For Remote Consultation
For Illness Diagnose
Other

Segment by Application
Clinic & Hospitals
Field Medical Training
Earthquake Relief
Other

Segment by Regions
North America
Europe
China
Japan

Regional Analysis

the Telemedicine Carts & Systems market is a small market that concentrates on specific needs of the target market. To understand the Telemedicine Carts & Systems market better, it was segmented into different regions that include China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia, and Vietnam in Asia Pacific; United States, Canada and Mexico in North America; Germany, UK, France, Italy, Russia and Turkey and others in Europe; Brazil in Latin America, Egypt and Gulf Cooperation Council countries in Middle East and Africa. The regional markets were further segmented based on customers. Asia-Pacific is shown to have a huge percentage of the market share followed by Egypt and GCC countries in the Middle East. As per the study, Asia-Pacific region will grow at the highest CAGR over the forecast period.

Leave a Query @ https://www.wiseguyreports.com/enquiry/4942739-global-telemedicine-carts-systems-market-research-report-2020

Table of Contents

1 Telemedicine Carts & Systems Market Overview
1.1 Product Overview and Scope of Telemedicine Carts & Systems
1.2 Telemedicine Carts & Systems Segment by Type
1.2.1 Global Telemedicine Carts & Systems Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 For Remote Consultation
1.2.3 For Illness Diagnose
1.2.4 Other
1.3 Telemedicine Carts & Systems Segment by Application
1.3.1 Telemedicine Carts & Systems Consumption Comparison by Application: 2020 VS 2026
1.3.2 Clinic & Hospitals
1.3.3 Field Medical Training
1.3.4 Earthquake Relief
1.3.5 Other
1.4 Global Telemedicine Carts & Systems Market by Region
1.4.1 Global Telemedicine Carts & Systems Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Telemedicine Carts & Systems Growth Prospects
1.5.1 Global Telemedicine Carts & Systems Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Telemedicine Carts & Systems Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Telemedicine Carts & Systems Production Estimates and Forecasts (2015-2026)

….

2 Market Competition by Manufacturers

..

7 Company Profiles and Key Figures in Telemedicine Carts & Systems Business
7.1 GlobalMed
7.1.1 GlobalMed Telemedicine Carts & Systems Production Sites and Area Served
7.1.2 GlobalMed Telemedicine Carts & Systems Product Introduction, Application and Specification
7.1.3 GlobalMed Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 GlobalMed Main Business and Markets Served
7.2 Rubbermaid Healthcare
7.2.1 Rubbermaid Healthcare Telemedicine Carts & Systems Production Sites and Area Served
7.2.2 Rubbermaid Healthcare Telemedicine Carts & Systems Product Introduction, Application and Specification
7.2.3 Rubbermaid Healthcare Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Rubbermaid Healthcare Main Business and Markets Served
7.3 Polycom
7.3.1 Polycom Telemedicine Carts & Systems Production Sites and Area Served
7.3.2 Polycom Telemedicine Carts & Systems Product Introduction, Application and Specification
7.3.3 Polycom Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Polycom Main Business and Markets Served
7.4 Cisco Systems
7.4.1 Cisco Systems Telemedicine Carts & Systems Production Sites and Area Served
7.4.2 Cisco Systems Telemedicine Carts & Systems Product Introduction, Application and Specification
7.4.3 Cisco Systems Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Cisco Systems Main Business and Markets Served
7.5 Ergotron
7.5.1 Ergotron Telemedicine Carts & Systems Production Sites and Area Served
7.5.2 Ergotron Telemedicine Carts & Systems Product Introduction, Application and Specification
7.5.3 Ergotron Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Ergotron Main Business and Markets Served
7.6 AVTEQ
7.6.1 AVTEQ Telemedicine Carts & Systems Production Sites and Area Served
7.6.2 AVTEQ Telemedicine Carts & Systems Product Introduction, Application and Specification
7.6.3 AVTEQ Telemedicine Carts & Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 AVTEQ Main Business and Markets Served
7.7 AMD
7.8 Lifebot
7.9 Avizia
7.10 ICUcare
7.11 METRO
7.12 Intouch Health
7.13 Afc Industries
7.14 AFHCAN

Continued…

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4942739

           

Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Seceon aiSIEM™ Secures Healthcare IoT and IIoT Devices with CSPi ARIA SDS Solution

Integrates Seceon aiSIEM with CSPi’s ARIA SDS to Stop IoT Cyberthreats While Allowing Critical Applications and Devices to Continue to Operate

CSPi (NASDAQ:CSPI)

Challenges with the vast variety of IoT devices are multifold with over 70% of them being unmanaged & unsecured. CSPi’s proven, innovative approach to protect IoT devices makes them an ideal partner”

— Chandra Pandey, Founder & CEO of Seceon

WESTFORD, MA, USA, February 24, 2020 /EINPresswire.com/ — Seceon, which pioneered the first fully-automated, real-time cyber threat detection, containment and elimination platform, along with with strategic technology partner CSPi (NASDAQ: CSPI) announced today a joint solution combining Seceon’s aiSIEM with CSPi’s ARIA Software Defined Security (SDS) solution offering enterprises and service providers a best-in-class solution for securing Healthcare IoT and IIoT devices by detecting and stopping cyber threats in real-time while allowing critical applications and devices to operate without interruption.

The combined solution is immensely valuable especially when blocking all communication is possible but allowing the good communication while blocking the bad is critical if the endpoint in question must keep working. Such is the case with Healthcare IoT devices, such as, pace makers, insulin pumps, and other Industrial IoT devices, where stopping all communication from such devices could be life threatening. This is a huge benefit compared to the other remediation techniques that exist today that either takes out the end point entirely, block all communication from it, or shuts down the critical applications with which it communicates.

“The challenge with that vast variety of IoT devices is multifold with over 70% of them being unmanaged and unsecured. CSPi’s proven, innovative approach to protect IoT devices makes them an ideal partner for Seceon,” said Chandra Pandey, Founder and CEO of Seceon. He added, “Together, CSPi’s ARIA SDS solution and aiSIEM provides comprehensive cybersecurity by safeguarding digital assets, at a price enterprises and service providers can afford.” According to Sunil Kotagiri, Co-Founder and Engineering Head of Seceon, “The joint solution really shines with aiSIEM’s unique ability to take automatic action to stop the breaches once it detects them. Seceon aiSIEM can instruct CSPi’s ARIA SDS devices resident in-line in the network using advanced and open APIs to stop specific threat conversations without having to quarantine the whole device. Ability to surgically stop specific malicious conversations while letting the device continue to operate and perform normal operations is extremely critical, especially if the device is a life-saving medical instrument. This is a breakthrough innovation that no other vendor in the industry can come close to matching”.

Victor Dellovo, President and CEO at CSPi said, “Enterprises today are struggling to protect IoT devices from the pace of growing and sophisticated cyberthreats.” He further added, “CSPi developed ARIA SDS, a comprehensive cybersecurity platform and applications, that allows IoT devices to be detected and monitored by looking through the network data as it flows in from such devices and also classifying the data on the fly without impacting its delivery. This allows monitoring for such devices in network aggregation points – typically one step back in the wireline network. Seceon’s aiSIEM is one of the best at detecting and stoping IIoT threats and is key in the joint solution to enable ARIA to stop the specific threat conversations without taking out the endpoint or blocking all communication with it.”

To learn more about the solution, go to: https://go.cspi.com/aria-pi-threat-reaper-aisiem/ or watch the on-demand webinar: https://info.ariacybersecurity.com/detect_and_stop_cyberthreats

About Seceon
Seceon empowers Enterprises and MSSPs to provide “Comprehensive Cybersecurity for the Digital-Era”, through the coalescence of Seceon’s Dynamic Threat Models, Machine Learning and Artificial Intelligence (AI) with actionable contextual awareness to proactively surface threats and breaches that matter as well as to automatically contain and eliminate them in real-time. Seceon’s Open Threat Management (OTM) platform scales to millions of assets to collect raw data such as streaming logs, network flows and identities from all apps, devices, network infrastructure and cloud infrastructure including SaaS, PaaS, IaaS, IoTs and IIoTs, as well as advanced threat intelligence to provide comprehensive visibility of users, hosts, applications, and services. aiSIEM™ and aiMSSP™ are award-winning solutions built on the OTM platform to support enterprise Comprehensive Cybersecurity and MSSPs offering aiMDR, aiSOC and aiSIEM services with flexible deployment models. To learn more, please visit: www.seceon.com or call (978) 923-0040 and follow the company on: Twitter | Facebook | LinkedIn

About CSPi
CSPi (NASDAQ: CSPI) operates two divisions, each with unique expertise in designing and implementing technology solutions to help their customers use technology as a means to success. The High Performance Product division, including the Cybersecurity Center of Excellence, originated from supporting initiatives for the Department of Defense and Western intelligence agencies related to network monitoring, data protection, and intelligence initiatives. This focused mindset now results in foolproof data protection, enterprise-wide. Our ARIA Software Defined Security suite provides enhanced network security, as well as accelerating incident response capabilities, while our Myricom nVoy Series appliances provide automated breach identification and notification, enabled by the 10G dropless packet capture inherent in our Myricom intelligent adapters. CSPi’s Technology Solutions division helps clients achieve their business goals and accelerate time to market through innovative IT solutions and professional services by partnering with best-in-class technology providers. For organizations that want the benefits of an IT department without the cost, we offer a robust catalog of Managed IT Services providing 24×365 proactive support. Our team of engineers have expertise across major industries supporting five key technology areas: Advanced Security; Communication and Collaboration; Data Center; Networking; and Wireless & Mobility. For more information, please visit www.cspi.com

CSPi Press Contact:
Amy Carey
Amy.carey@cspi.com

Seceon Press Contact:

Arun Gandhi
Seceon Inc.
+1 978-923-0040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Secure Channels to Unveil New Cybersecurity Deployments at RSA 2020

Booth 2431 to Feature Premium-Grade Encryption and Partner Solutions

IRVINE, CA, UNITED STATES, February 24, 2020 /EINPresswire.com/ — Secure Channels Inc. starts its tradeshow season Feb. 24 to 27 at the RSA Conference 2020 at the Moscone Center in San Francisco. The cybersecurity leader will showcase at Booth 2431 new technological deployments for its upgraded products and outline solutions devised to fill widening cybersecurity gaps.

Visitors to the booth will see how Secure Channels’ premium-grade encryption, XOTIC Core, effectively protects IoT digital transformations. As 5G service fuels the spread of connected devices, those reliant on the technology to safely store and transmit sensitive data are often under-protected by their cybersecurity limitations. IoT devices, components and sensors optimized for peak performance, battery life and cost generally lack the resources to host strong encryption. XOTIC Core is Secure Channels’ lightweight, efficient post-quantum cryptosystem that fits and functions in resource-constrained technologies. XOTIC Core supplies high-performance encryption to several technologies with easily-targeted vulnerabilities as they’re brought online, like OT/critical infrastructure, network cameras and vehicle telemetry systems.

Attendees will also learn about Secure Channels’ Enterprise Key Management solution using Thales/ Gemalto’s SafeNet KeySecure k170v platform. The solution revolutionizes cloud data backup practices by improving the security and utility of backups. Instead of traditional cloud-bound backups that encrypt at the volume level with a single key, the Enterprise Key Management solution leverages XOTIC’s granularity to encrypt every piece of data with its own symmetric key. The stream of keys are distributed to the virtual key management appliance, and can be easily retrieved to access individual data. This surgical granularity improves the utility of cloud data backups, reduces data exposure for reference tasks and gives organizations greater control over their key management practices.

Secure Channels staff will also aid developers and system integrators in testing XOTIC for themselves. An XOTIC SDK is now available as a trial version in our booth at RSA and Oracle Marketplace. The SDK, ideal for enterprise applications and third-party software, allows developers and integrators to test XOTIC’s strong, efficient encryption on their systems. Secure Channels will help visitors to access the XOTIC SDK and many other premium-grade solutions filling a range of cybersecurity gaps.

Secure Channels CEO Richard Blech looks forward to showing the IT and cybersecurity communities the company’s path for the coming year. “The RSA shows are always an exciting time for us as we welcome every opportunity to connect or re-connect with our peers and potential partners. We’re all there fueled by the same drive — data security in our increasingly-connected world — and the people at Secure Channels will be there, eager to show the future-ready solutions we’ve readied to meet that goal.”

About Secure Channels
Secure Channels is a cybersecurity solutions development company based in Irvine, Calif. Our experts engineer and develop high-performance, cost-effective cybersecurity technologies as platform-agnostic software and hardware-ready solutions to protect against present and emerging threats. Our award-winning, cryptanalyst-celebrated solutions include advanced data protection, no-friction encryption, authentication, enterprise confidentiality solutions and proximity-based monitoring and intelligence capabilities. Learn more at https://securechannels.com/

Press kit available through Business Wire at http://www.tradeshownews.com/events/rsa-conference-2020/secure-channels-inc/

Contact
Secure Channels Inc.
+1 949-679-5736
email us here


Source: EIN Presswire

Valtix Achieves AWS Advanced Technology Partner Tier

Unboxing Cloud Network Security with Valtix and AWS

AWS Marketplace - Valtix Network Security Service

AWS Marketplace – Valtix Network Security Service

Valtix Achieves AWS Advanced Technology Partner Tier and Enterprise Contract Enablement

Increasingly, AWS has delivered many integrated native security solutions to protect enterprise applications and data in the cloud.”

— Vishal Jain, Co-Founder and CEO, Valtix

SANTA CLARA, CA, UNITED STATES, February 24, 2020 /EINPresswire.com/ — SANTA CLARA, Calif. – February 24, 2020 – Valtix, the developer of the cloud-native firewall and network security as a service, announced today that it has achieved Advanced Technology Partner status in the Amazon Web Services (AWS) Partner Network (APN). The new APN Partner status recognizes Valtix’s ability to deliver SaaS cloud-native network security service with fast time-to-protection and time-to-value across the enterprise applications in the cloud, which can exponentially increase software agility and consistently protect workloads in the cloud.

To attain APN Advanced Technology Partner status, Valtix has established an innovative cloud-native network security service certified via AWS’s stringent technical certification. Additionally, Valtix has validated its expertise through a wide range of enterprise references that demonstrate strong customer value by eliminating security firewall appliance management and operational challenges with a SaaS-based Cloud Controller.

With a focus on an advanced network security service approach and simplifying enterprise security operations, Valtix is also included in the Enterprise Contract for AWS Marketplace, which gives large enterprise customers the option to purchase software solutions using a standardized contract template under which participating sellers have agreed to offer their products. AWS customers that approve use of the Enterprise Contract for AWS Marketplace can immediately subscribe and deploy Valtix network security service including Next-Generation Firewall (NGFW) and Web Application Firewall (WAF) across AWS Availability Zones, AWS accounts, and AWS Regions. These services are designed to protect Internet-facing applications from advanced attacks and prevent data exfiltration on outbound flows.

“Increasingly, AWS has delivered many integrated native security solutions to protect enterprise applications and data in the cloud,” said Vishal Jain, CEO and Co-Founder, Valtix. “We are pleased to elevate our relationship as an APN Advanced Technology Partner so that we can help our shared customers to accelerate their digital transformation by leveraging AWS to reduce complexity, cost, and increase agility while keeping their cloud applications secure.”

Valtix delivers enterprise network security service in the cloud combined with the automation, scale, and agility of network security as a service, ensuring protection of cloud application workflows while reducing cloud security complexity for its customers.

If you want an enterprise-grade network security service without constraints, while also taking full advantage of the scale, economics, and elasticity the cloud has to offer, try out Valtix Sandbox Free Tier in AWS Marketplace.

For More Information:

– Visit Valtix at RSA Early Stage Expo Booth #30 in San Francisco Moscone Center South
– Watch On-Demand Webinar on "Get Ahead of Cloud Network Security Trends and Practices with AWS and Valtix"
– Register Live Webinar on March 4, 2020 on "Unboxing Cloud Network Security with AWS and Valtix"

About Valtix

Valtix offers a cloud-native network security service to secure enterprise cloud apps and workloads. Valtix service provides time-to-value and reduces operational complexity to enable enterprises to move to the cloud as fast as their business wants to. The platform enables enterprises to rapidly transform the public cloud into the new datacenter while maintaining security policies and standards. To learn more, please email info@valtix.com.

Cynthia Hsieh
Valtix Inc.
+1 650-420-6014
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Ricovr Healthcare Announces Prominent Industry Leaders to its Advisory Board

Ricovr Healthcare

Advisors Include Former Chairman & CEO Of Quest Diagnostics, Former CEO Of Spirit Airlines, And Former Senior Partner Of Goldman Sachs

I am honored to join the advisory board of Ricovr as I believe in the Company’s mission and the
urgent need for innovation in the diagnostics field.”

— Surya N. Mohapatra, Ph.D. Former Chairman & CEO Of Quest Diagnostics

PRINCETON, NEW JERSEY, UNITED STATES, February 24, 2020 /EINPresswire.com/ — Ricovr Healthcare, a New Jersey-based innovative oral diagnostic company, today announced the formation of the advisory board.

The advisory board includes Surya N. Mohapatra, former Chairman & CEO of Quest Diagnostics (DGX), Ben Baldanza, former CEO & President of Spirit Airlines (SAVE), and Kevin Quinn, former Partner & Co-Head of Global Technology Banking of Goldman Sachs (GS). Ricovr is developing state-of-the-art technology for oral point-of-care testing, which will benefit businesses, law enforcement officials, and the medical community.

“We are pleased to announce distinguished business leaders to our advisory board,” said Dr. Himanshu Bhatia, Founder, and CEO of Ricovr Healthcare. “We thoughtfully curated this board to include drug testing, transportation, Hi-Tech, and government-industry experts who will provide Ricovr the guidance on strategy and Go-to-market priorities.”

“I am honored to join the advisory board of Ricovr as I believe in Company’s mission and the urgent need for innovation in the diagnostics field,” said Surya N. Mohapatra, Ph.D.

“Coming from the transportation industry, I see how Ricovr’s technology can improve safety and productivity not only for Airlines but also for ground transportation operators, warehouses, security officers, and even parents,” said Ben Baldanza.

Oral diagnostics is a fast-growing market and Riocvr has the right technology and execution team to disrupt the industry,” said Kevin Quinn.

Ricovr Healthcare is currently working on a biosensor technology to manufacture and commercialize revolutionary oral point-of-care medical devices for use in diverse markets. The devices are expected to speed up the screening and monitoring of medical diagnostics. Ricovr is expected to announce more information about the devices in the coming days.

About Ricovr
Ricovr was founded by Dr. Himanshu Bhatia, a physician executive with a deep background in medical devices and biotechnology. Piyush Sadana, Co-Founder, is a seasoned technology entrepreneur with an investment banking background. The firm boasts a distinguished team of scientists and engineers committed to making a positive impact on society. In addition, the company has strong partnerships with leading research and development institutions around the globe.

For more information, visit www.ricovr.com.

Kyle Muse
Ricovr Healthcare
+1 609-375-8379
email us here


Source: EIN Presswire